正在加载图片...
奥美拉唑Omeprazole Proton Pump Inhibitor(PPL,质子泵抑制剂 A proton pump inhibitor used in the treatment of peptic ulcer disease(PUD),gastroesophageal reflux disease (GORD/GERD),laryngopharyngeal reflux(LPR)and Zollinger-Ellison syndrome. Weak base that enters parietal cells easily A prodrug that is activated in low pH(applies to all PPIs). CYP2C19 metabolized;T=1 h,effect lasts 24-48 h. Other Proton Pump Inhibitor(其它质子泵抑制剂) 兰索拉唑Lansoprazole 泮托拉唑Pantoprazole 雷贝拉唑Rabeprazole 埃索美拉唑Esomeprazole 33 奥美拉唑 Omeprazole A proton pump inhibitor used in the treatment of peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD), laryngopharyngeal reflux (LPR) and Zollinger–Ellison syndrome. Weak base that enters parietal cells easily A prodrug that is activated in low pH (applies to all PPIs). CYP2C19 metabolized; T ½ = 1 h, effect lasts 24-48 h. Proton Pump Inhibitor (PPI, 质子泵抑制剂) 兰索拉唑 Lansoprazole Other Proton Pump Inhibitor (其它质子泵抑制剂) 泮托拉唑 Pantoprazole 雷贝拉唑 Rabeprazole 埃索美拉唑 Esomeprazole
<<向上翻页向下翻页>>
©2008-现在 cucdc.com 高等教育资讯网 版权所有